Blind Fascia Iliaca Compartment Block Compared to Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures
NCT ID: NCT05365555
Last Updated: 2022-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2022-05-01
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lateral Cutaneous Nerve and PENG Blocks Versus Suprainguinal Fascia Iliaca Block in Post-op Analgesia of Hip Fractures
NCT05749367
Optimization of Analgesia for Hip Fracture Patients
NCT03609645
Surgical Treatment of Hip Fractures Under Peripheral Regional Anesthesia
NCT04005404
Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures
NCT01701414
Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur
NCT05705726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study proposes to compare the widely used technique of a blind fascia iliaca compartment block (FICB) to an ultrasound-guided femoral nerve block (FNB) that is currently being rolled out locally as an alternative. During the implementation period of this new clinical routine, it will be possible to compare the efficacy of FICB and FNB in reducing participant-reported pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fascia Iliaca Compartment Block (FICB)
Participants with a radiologically verified hip fracture receiving a FICB using a blind technique guided by anatomical landmarks.
Fascia Iliaca Compartment Block
Blind technique.
Ropivacaine
Ropivacaine dosed according to local guidelines.
Femoral Nerve Block (FNB)
Participants with a radiologically verified hip fracture receiving a FNB using ultrasound guidance for direct nerve visualisation.
Femoral Nerve Block
Ultrasound guided.
Ropivacaine
Ropivacaine dosed according to local guidelines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fascia Iliaca Compartment Block
Blind technique.
Femoral Nerve Block
Ultrasound guided.
Ropivacaine
Ropivacaine dosed according to local guidelines.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Isolated pelvic or diaphyseal femur fracture
* Patients unable to communicate regardless of reason
* Patients with contraindications to receiving a peripheral nerve block with an amide local anaesthetic according to local guidelines
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Linkoeping
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Wilhelms
MD, Emergency Department Head of Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Wilhelms, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Linköping
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akutmottagningen US Östergötland
Linköping, Östergötland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SE2021-05967-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.